RecruitingPhase 3NCT03859921

Oral Dydrogesterone as Luteal Phase Support in Natural Cycle FET

A Randomized Double Blind Controlled Comparison of Oral Dydrogesterone as Luteal Phase Support in Natural Cycle Frozen-thawed Embryo Transfer

Sponsor

The University of Hong Kong

Enrollment

716 participants

Start Date

Jul 1, 2021

Study Type

INTERVENTIONAL

Conditions

Subfertility

Summary

This randomised double-blinded controlled trial aims to compare the live birth rate in natural FET cycles with and without oral dydrogesterone as luteal phase support. The hypothesis is that the use of oral dydrogesterone will increase the live birth rate of natural cycle FET.

Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 42 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Dydrogesterone and a drug called Placebo for people with subfertility. The study is currently recruiting participants at 1 location. People eligible for this study include women aged 18 Years to 42 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.